Investors are on the edge of their collective seats, hoping that Genesco
What analysts say:
- Buy, sell, or hold?: Analysts strongly back Genesco, with nine of 10 rating it a buy and the remainder rating it a hold. Analysts like Genesco better than competitor Finish Line overall. Analysts still rate the stock a moderate buy, but they are a bit more wary about it compared to three months ago.
- Revenue Forecasts: On average, analysts predict $447.1 million in revenue this quarter. That would represent a rise of 22.9% from the year-ago quarter.
- Wall Street Earnings Expectations: The average analyst estimate is earnings of $0.10 per share. Estimates range from $0.07 to $0.12.
What our community says:
CAPS All Stars are solidly behind the stock, with 91.5% awarding it an "outperform" rating. The community at large concurs with the All Stars, with 87.2% assigning it a rating of "outperform." Fools are gung-ho about Genesco, though the message boards have been quiet lately with only 59 posts in the past 30 days. Despite the majority sentiment in favor of Genesco, the stock has a middling CAPS rating of three out of five stars.
Management:
Revenue has now gone up for three straight quarters.
Now let's look at how efficient management is at running the business. Traditionally, margins represent the efficiency with which companies capture portions of sales dollars. The following table shows gross, operating, and net margins over the past four quarters:
|
Quarter |
Q1 |
Q4 |
Q3 |
Q2 |
|
Gross Margin |
51.4% |
48.7% |
50.9% |
50.6% |
|
Operating Margin |
5.3% |
8.6% |
5.7% |
(0.9%) |
|
Net Margin |
3.1% |
5.5% |
3.6% |
(0.9%) |
We can help you keep tabs on your companies with My Watchlist, our free, personalized service. Add Genesco now.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
